MMCM
IDXX icon

Murphy & Mullick Capital Management’s Idexx Laboratories IDXX Stock Holding History

Murphy & Mullick Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2K Hold
25
– – 0.01% 462
2026
Q1 		$14K Buy
+25
New +$16K 0.01% 436

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Murphy & Mullick Capital Management's IDXX Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 25 shares worth $13.2K. The position accounts for 0.01% of the portfolio, ranked #462.

Murphy & Mullick Capital Management first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $14K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Murphy & Mullick Capital Management held 25 shares of Idexx Laboratories worth $13.2K as of Q2 2026.
  • Murphy & Mullick Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #462 holding.
  • Murphy & Mullick Capital Management first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Murphy & Mullick Capital Management's Idexx Laboratories position peaked at $14K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.